History and Physical Examination Findings to Trigger PSQ Administration in Children with Cleft History
Every child with a history of cleft lip and/or palate should be screened for snoring at every health maintenance visit, and any child who snores habitually (≥3 nights per week) should complete the Pediatric Sleep Questionnaire. 1, 2
Mandatory Screening Triggers
Nocturnal Symptoms
- Habitual snoring (≥3 nights per week) is the single most important trigger—this symptom alone mandates PSQ administration 1, 2
- Witnessed apneas with gasping or snorting sounds during sleep 1
- Labored breathing during sleep 1
- Sleep enuresis, particularly secondary enuresis (new-onset bedwetting after ≥6 months of continence)—this is a high-risk nocturnal symptom that should prompt immediate evaluation 1, 2
- Unusual sleep postures such as neck hyperextension or sleeping in a seated position 1
- Restless sleep with frequent position changes 2
Daytime Behavioral and Neurocognitive Symptoms
- Daytime sleepiness or others commenting that the child appears sleepy (76.2% positive predictive value for OSA) 1, 3
- Attention-deficit/hyperactivity symptoms or inattention 1
- Learning problems or poor school performance 1
- Behavioral problems including aggression, defiant behavior, anxiety, or mood disturbances 1, 4
Growth and Cardiovascular Concerns
- Failure to thrive or poor weight gain 1
- Obesity (BMI >95th percentile) 1, 2
- Hypertension on examination 1
- Headaches upon awakening 1
Physical Examination Findings
Oropharyngeal Assessment
- Tonsillar hypertrophy graded 3+ to 4+ (occupying ≥50% of oropharyngeal space between anterior tonsillar pillars) 1, 2
- Note: Children with cleft have significantly less tonsillar enlargement than non-cleft children with OSA (33% vs 79%), so absence of tonsillar hypertrophy does NOT exclude OSA risk 5
Craniofacial Features
Growth Parameters
- Document weight, height, and BMI percentile—both underweight and overweight status increase OSA risk 1, 2
Cardiovascular Examination
- Measure blood pressure and compare to age-adjusted norms—elevated BP suggests OSA complications 1, 2
High-Risk Syndromic Populations Requiring Lower Threshold
Children with 22q11.2 deletion syndrome have approximately 50% prevalence of positive OSA screening—these patients warrant PSQ administration even with minimal symptoms 2, 3. The highest risk for positive screening occurs in:
- 22q11.2 deletion syndrome (50% screen positive) 2, 3
- Pierre Robin sequence 2, 3
- Males (increased risk compared to females) 3
- Non-Caucasian children with cleft 3
Critical Clinical Pitfalls
History and physical examination alone correctly identify OSA in only 55% of children with suspected disease—objective screening with the PSQ is essential because clinical assessment is unreliable 2. Key mistakes to avoid:
- Do not assume absence of snoring excludes OSA—caregivers may not observe intermittent nocturnal snoring 1
- Do not rely on tonsillar size—cleft patients have less tonsillar hypertrophy than typical OSA patients but similar disease severity 5
- Do not wait for daytime sleepiness—children manifest OSA differently than adults, with behavioral problems and inattention being more common than frank sleepiness 1
- Do not dismiss mild symptoms in syndromic patients—particularly those with 22q11.2 deletion syndrome who have markedly elevated OSA prevalence 2, 3
Practical Template Components
Your clinical template should include these specific yes/no checkboxes:
- Does the child snore ≥3 nights per week? 1, 2
- Have you witnessed apneas or gasping during sleep? 1
- Does the child have new-onset bedwetting? 1, 2
- Do others comment the child appears sleepy during the day? 3
- Does the child have attention problems or hyperactivity? 1
- Has growth been poor or is the child obese? 1
- Tonsillar grade (0 to 4+) 1
- Blood pressure percentile for age 1
- Underlying syndrome (especially 22q11.2 deletion)? 2, 3
If any nocturnal symptom is present OR if the child has 22q11.2 deletion syndrome, administer the PSQ immediately. 1, 2, 3